Maria Jose Duenas Decamp PhD
Title | Assistant Professor |
---|
Institution | UMass Chan Medical School |
---|
Department | Medicine |
---|
vCard | Download vCard |
---|
|
|
|
|
Institution | T.H. Chan School of Medicine |
---|
Department | Medicine |
---|
Division | Infectious Diseases |
---|
|
---|
|
Overview
Our research is focused on HIV infection in hematopoietic stem and progenitor cells (HSPC).
Research
P30 AI042845-14 (Duenas Decamp, Maria Jose)Nov 1, 2011 - Nov 1, 2012 University of Massachusetts Center for AIDS Research (CFAR) pilot study HIV-1-infected Hematopoietic Stem/Progenitor Cells differentiation and tropism implication for HSPC infection. Role: Principal investigator |
|
R21NS097145 (Duenas-Decamp, Maria)Mar 1, 2016 - Feb 28, 2018 NIH HIV-1 infection of hematopoietic progenitor cells, their differentiation and seeding of virus into brain tissue Role: Co-Principal Investigator |
Bibliographic
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Beauparlant D, Rusert P, Magnus C, Kadelka C, Weber J, Uhr T, Zagordi O, Oberle C, Duenas-Decamp MJ, Clapham PR, Metzner KJ, G?nthard HF, Trkola A. Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality. PLoS Pathog. 2017 03; 13(3):e1006255.
PMID: 28264054.
Citations:
16 Fields:
Translation:
HumansCells
-
Duenas-Decamp M, Jiang L, Bolon D, Clapham PR. Saturation Mutagenesis of the HIV-1 Envelope CD4 Binding Loop Reveals Residues Controlling Distinct Trimer Conformations. PLoS Pathog. 2016 Nov; 12(11):e1005988.
PMID: 27820858.
Citations:
14 Fields:
Translation:
HumansCells
-
O'Connell O, Repik A, Reeves JD, Gonzalez-Perez MP, Quitadamo B, Anton ED, Duenas-Decamp M, Peters P, Lin R, Zolla-Pazner S, Corti D, Wallace A, Wang S, Kong XP, Lu S, Clapham PR. Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism. J Virol. 2013 Jan; 87(1):187-98.
PMID: 23055568.
Citations:
17 Fields:
Translation:
HumansCells
-
Due?as-Decamp MJ, O'Connell OJ, Corti D, Zolla-Pazner S, Clapham PR. The W100 pocket on HIV-1 gp120 penetrated by b12 is not a target for other CD4bs monoclonal antibodies. Retrovirology. 2012 Jan 27; 9:9.
PMID: 22284192.
Citations:
8 Fields:
Translation:
HumansCells
-
Vaine M, Duenas-Decamp M, Peters P, Liu Q, Arthos J, Wang S, Clapham P, Lu S. Two closely related Env antigens from the same patient elicited different spectra of neutralizing antibodies against heterologous HIV-1 isolates. J Virol. 2011 May; 85(10):4927-36.
PMID: 21411542.
-
Musich T, Peters PJ, Duenas-Decamp MJ, Gonzalez-Perez MP, Robinson J, Zolla-Pazner S, Ball JK, Luzuriaga K, Clapham PR. A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection. J Virol. 2011 Mar; 85(5):2397-405.
PMID: 21159865.
Citations:
45 Fields:
Translation:
HumansCells
-
Duenas-Decamp MJ, Clapham PR. HIV-1 gp120 determinants proximal to the CD4 binding site shift protective glycans that are targeted by monoclonal antibody 2G12. J Virol. 2010 Sep; 84(18):9608-12.
PMID: 20610714.
Citations:
19 Fields:
Translation:
HumansCells
-
Duenas-Decamp MJ, Peters PJ, Repik A, Musich T, Gonzalez-Perez MP, Caron C, Brown R, Ball J, Clapham PR. Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis. Future Virol. 2010 Jul; 5(4):435-451.
PMID: 20930940.
Citations:
-
Duenas-Decamp MJ, Peters PJ, Burton D, Clapham PR. Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopes. J Virol. 2009 Mar; 83(6):2575-83.
PMID: 19129457.
Citations:
55 Fields:
Translation:
HumansCells
-
Duenas-Decamp MJ, Peters P, Burton D, Clapham PR. Natural resistance of human immunodeficiency virus type 1 to the CD4bs antibody b12 conferred by a glycan and an arginine residue close to the CD4 binding loop. J Virol. 2008 Jun; 82(12):5807-14.
PMID: 18385254.
Citations:
42 Fields:
Translation:
HumansCells
-
Peters PJ, Duenas-Decamp MJ, Sullivan WM, Brown R, Ankghuambom C, Luzuriaga K, Robinson J, Burton DR, Bell J, Simmonds P, Ball J, Clapham PR. Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors. Retrovirology. 2008 Jan 18; 5:5.
PMID: 18205925.
Citations:
59 Fields:
Translation:
HumansCells
-
Peters PJ, Due?as-Decamp MJ, Sullivan WM, Clapham PR. Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues. J Neuroimmune Pharmacol. 2007 Mar; 2(1):32-41.
PMID: 18040824.
Citations:
24 Fields:
Translation:
HumansAnimalsCells
-
Peters PJ, Sullivan WM, Duenas-Decamp MJ, Bhattacharya J, Ankghuambom C, Brown R, Luzuriaga K, Bell J, Simmonds P, Ball J, Clapham PR. Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis. J Virol. 2006 Jul; 80(13):6324-32.
PMID: 16775320.
Citations:
71 Fields:
Translation:
HumansCells
-
DueƱas, M.J. and Estrada P. Immobilization of B-Xylosidase from Trichoderma Reesei QM 9414 on nylon powder. Bio-catalysis and Biotransformatio. 1996;17:139-16.
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
Year | Publications |
---|
2006 | 2 |
2008 | 2 |
2009 | 1 |
2010 | 3 |
2011 | 1 |
2012 | 2 |
2016 | 1 |
2017 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs